Paraviral cutaneous manifestations associated to SARS-CoV-2 Omicron variant

References

• Machhi J, Herskovitz J, Senan AM, et al. The natural history, pathobiology, and clinical manifestations of SARS-CoV-2 infections. J Neuroimmune Pharmacol. 2020;15(3):359–386.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Statement on the second meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV); 2020 [cited 2022 May 12]. Available from: https://www.who.int/news/item/30-01-2020-statement-on-the-second-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-novel-coronavirus-(2019-ncov).
   Google Scholar
• World Health Organization. WHO Director-General’s opening remarks at the media briefing on COVID-19; 2020 [cited 2022 May 12]. Available from: https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19–-11-march-2020.
   Google Scholar
• Singh PK, Kulsum U, Rufai SB, et al. Mutations in SARS-CoV-2 leading to antigenic variations in spike protein: a challenge in vaccine development. J Lab Physicians. 2020;12(2):154–160.
   PubMedGoogle Scholar
• Andrews N, Stowe J, Kirsebom F, et al. Covid-19 vaccine effectiveness against the omicron (B.1.1.529) variant. N Engl J Med. 2022;386(16):1532–1546.
   PubMed Web of Science ®Google Scholar
• O’Toole Á, Scher E, Underwood A, et al. Assignment of epidemiological lineages in an emerging pandemic using the pangolin tool. Virus Evol. 2021;7(2):veab064.
   PubMed Web of Science ®Google Scholar
• Callaway E. Heavily mutated omicron variant puts scientists on alert. Nature. 2021;600(7887):21.
   PubMed Web of Science ®Google Scholar
• Tzou PL, Tao K, Pond SLK, et al. Coronavirus resistance database (CoV-RDB): SARS-CoV-2 susceptibility to monoclonal antibodies, convalescent plasma, and plasma from vaccinated persons. PLOS ONE. 2022;17(3):e0261045.
   PubMed Web of Science ®Google Scholar
• Ramírez JD, Castañeda S, Ballesteros N, PSP Study Group, et al. Hotspots for SARS‐CoV‐2 omicron variant spread: lessons from New York city. J Med Virol. 2022;94(7):2911–2914.
   PubMed Web of Science ®Google Scholar
• Marzano AV, Genovese G, Moltrasio C, Italian Skin COVID-19 Network of the Italian Society of Dermatology and Sexually Transmitted Diseases, et al. The clinical spectrum of COVID-19–associated cutaneous manifestations: an Italian multicenter study of 200 adult patients. J Am Acad Dermatol. 2021;84(5):1356–1363.
   PubMed Web of Science ®Google Scholar
• Marzano AV, Cassano N, Genovese G, et al. Cutaneous manifestations in patients with COVID‐19: a preliminary review of an emerging issue. Br J Dermatol. 2020;183(3):431–442.
   PubMed Web of Science ®Google Scholar
• Le NK, Brooks JP. Acute urticaria as the initial presentation of COVID-19 in a pediatric patient. JAAD Case Rep. 2021;11:137–138.
   PubMedGoogle Scholar
• Genovese G, Moltrasio C, Berti E, et al. Skin manifestations associated with COVID-19: current knowledge and future perspectives. Dermatology. 2021;237(1):1–12.
   PubMed Web of Science ®Google Scholar
• Galván Casas C, Català A, Carretero Hernández G, et al. Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases. Br J Dermatol. 2020;183(1):71–77.
   PubMed Web of Science ®Google Scholar
• Freeman EE, McMahon DE, Lipoff JB, et al. The spectrum of COVID-19-associated dermatologic manifestations: an international registry of 716 patients from 31 countries. J Am Acad Dermatol. 2020;83(4):1118–1129.
   PubMed Web of Science ®Google Scholar
• Peroni A, Colato C, Schena D, et al. Urticarial lesions: if not urticaria, what else? The differential diagnosis of urticaria: part I. Cutaneous diseases. J Am Acad Dermatol. 2010;62(4):541–555.
   PubMed Web of Science ®Google Scholar
• Guerra KC, Toncar A, Krishnamurthy K. Miliaria. In: StatPearls. Treasure Island, FL: StatPearls Publishing; 2022.
   Google Scholar
• Phan T, Boes S, McCullough M, et al. Development of a one-step qualitative RT-PCR assay to detect the SARS-CoV-2 omicron (B.1.1.529) variant in respiratory specimens. J Clin Microbiol. 2022;60(3):e00024-22.
   PubMed Web of Science ®Google Scholar
• Cazzato G, Foti C, Colagrande A, et al. Skin manifestation of SARS-CoV-2: the Italian experience. JCM. 2021;10(8):1566.
   Google Scholar
• Classification of Omicron (B.1.1.529): SARS-CoV-2 variant of concern; 2022 [cited 2022 May 12]. https://www.who.int/news/item/26-11-2021-classification-of-omicron-(b.1.1.529)-sars-cov-2-variant-of-concern.
   Google Scholar
• Liu J, Li Y, Liu L, et al. Infection of human sweat glands by SARS-CoV-2. Cell Discov. 2020;6(1):84.
   PubMed Web of Science ®Google Scholar
• Mohta A, Mohta A, Nai RS, et al. An observational study of mucocutaneous manifestations among SARS-CoV-2 patients from three COVID-19 dedicated tertiary care centers. Indian Dermatol Online J. 2021;12(5):687–695.
   PubMedGoogle Scholar
• Criado PR, Criado RFJ, Gianotti R, et al. Urticarial vasculitis revealing immunolabelled nucleocapsid protein of SARS-CoV-2 in two Brazilian asymptomatic patients: the tip of the COVID-19 hidden iceberg? J Eur Acad Dermatol Venereol. 2021;35(9):e563–e566.
   PubMed Web of Science ®Google Scholar
• de Perosanz-Lobo D, Fernandez-Nieto D, Burgos-Blasco P, et al. Urticarial vasculitis in COVID-19 infection: a vasculopathy-related symptom? J Eur Acad Dermatol Venereol. 2020;34(10):e566–e568.
   PubMed Web of Science ®Google Scholar
• Nasiri S, Dadkhahfar S, Abasifar H, et al. Urticarial vasculitis in a COVID-19 recovered patient. Int J Dermatol. 2020;59(10):1285–1286.
   PubMed Web of Science ®Google Scholar
• Reinhart M, Metze D, Braun SA. Hautveränderungen bei COVID-19 und nach COVID-19-Impfung [Skin manifestations of COVID-19 and after COVID-19 vaccination]. Hautarzt. 2022;73(6):434–441.
   PubMed Web of Science ®Google Scholar
• Crisafulli G, Franceschini F, Caimmi S, et al. Mild cutaneous reactions to drugs. Acta Biomed. 2019;90(3-S):36–43.
   PubMedGoogle Scholar
• Rivera-Oyola R, Koschitzky M, Printy R, et al. Dermatologic findings in 2 patients with COVID-19. JAAD Case Rep. 2020;6(6):537–539.
   PubMedGoogle Scholar
• Recalcati S. Cutaneous manifestations in COVID‐19: a first perspective. J Eur Acad Dermatol Venereol. 2020;34(5):e212–e213.
   PubMed Web of Science ®Google Scholar
• Abuelgasim E, Dona ACM, Sondh RS, et al. Management of urticaria in COVID ‐19 patients: a systematic review. Dermatologic Therapy. 2021;34(1):e14328.
   PubMed Web of Science ®Google Scholar
• Magro C, Mulvey JJ, Berlin D, et al. Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases. Transl Res. 2020;220:1–13.
   PubMed Web of Science ®Google Scholar
• Zupin L, Moltrasio C, Genovese G, et al. SARS-CoV-2 does not replicate in HaCaT spontaneously immortalized human keratinocytes: implications for the pathogenesis of COVID-19-associated skin manifestations. Eur J Dermatol. 2022;32(1):143–145.
   Web of Science ®Google Scholar
• Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181(2):271–280.e8.
   PubMed Web of Science ®Google Scholar
• Lipsker D. Paraviral eruptions in the era of COVID-19: do some skin manifestations point to a natural resistance to SARS-CoV-2? Clin Dermatol. 2020;38(6):757–761.
   PubMed Web of Science ®Google Scholar
• Marzano AV, Genovese G, Fabbrocini G, et al. Varicella-like exanthem as a specific COVID-19-associated skin manifestation: multicenter case series of 22 patients. J Am Acad Dermatol. 2020;83(1):280–285.
   PubMed Web of Science ®Google Scholar
• Mitamura Y, Schulz D, Oro S, et al. Cutaneous and systemic hyperinflammation drives maculopapular drug exanthema in severely ill COVID-19 patients. Allergy. 2022;77(2):595–608.
   PubMed Web of Science ®Google Scholar
• Domizio JD, Gulen MF, Saidoune F, et al. The cGAS-STING pathway drives type I IFN immunopathology in COVID-19. Nature. 2022;603(7899):145–151.
   PubMed Web of Science ®Google Scholar
• Vafaeinezhad A, Atashzar MR, Baharlou R. The immune responses against coronavirus infections: friend or foe? Int Arch Allergy Immunol. 2021;182(9):863–876.
   PubMed Web of Science ®Google Scholar